Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Farmers Insurance
Argus Health
Healthtrust
Cerilliant
Moodys
QuintilesIMS
Chinese Patent Office
Daiichi Sankyo

Generated: May 24, 2018

DrugPatentWatch Database Preview

Details for Patent: 9,226,892

« Back to Dashboard

Which drugs does patent 9,226,892 protect, and when does it expire?

Patent 9,226,892 protects ASPIRIN and is included in one NDA.

This patent has eleven patent family members in nine countries.
Summary for Patent: 9,226,892
Title:pH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same
Abstract: Novel drug carriers capable of targeted and/or pH dependent release of biologically active agents into selected pH environments including the gastrointestinal (GI), ophthalmic, urinary, or reproductive tracts. Unexpectedly, carriers including free fatty acids (FFA) are able to deliver biologically active agents to various pH environments. Such targeted delivery is tailorable and useful for active agents that are: (a) injurious to the upper GI tract (esophagus, stomach, and duodenum), (b) acid labile, (c) impermeable/insoluble compounds in GI fluids, (d) susceptible to first pass metabolism, and/or (e) cause stomach irritation, upset, or dyspepsia.
Inventor(s): Marathi; Upendra K. (Houston, TX), Childress; Susann Edler (Houston, TX), Gammill; Shaun L. (Houston, TX), Strozier; Robert W. (Houston, TX)
Assignee: PLX PHARMA INC. (Houston, TX)
Application Number:13/791,189
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 9,226,892

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Plx Pharma ASPIRIN aspirin CAPSULE;ORAL 203697-001 Jan 14, 2013 OTC Yes Yes ➤ Sign Up ➤ Sign Up TREATMENT/PREVENTION OF CARDIOVASCULAR DISEASE ➤ Sign Up
Plx Pharma ASPIRIN aspirin CAPSULE;ORAL 203697-001 Jan 14, 2013 OTC Yes Yes ➤ Sign Up ➤ Sign Up TEMPORARY RELIEF OF MINOR ACHES AND PAINS ➤ Sign Up
Plx Pharma ASPIRIN aspirin CAPSULE;ORAL 203697-001 Jan 14, 2013 OTC Yes Yes ➤ Sign Up ➤ Sign Up TEMPORARY REDUCTION OF FEVER ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 9,226,892

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,216,150 pH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same ➤ Sign Up
9,730,884 pH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
US Department of Justice
AstraZeneca
Julphar
Chubb
Chinese Patent Office
Covington
Baxter
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.